Scihuhuan平台已收录预计检索 <10 秒
Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?
查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。
文献信息
- 题目
- Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?
- 作者
- Petra Rocic
- 发表年份
- 2012
- 期刊 / 来源
- Vascular Pharmacology
- 出版社
- Elsevier
- 文献类型
- 学术文献
- 平台记录更新
- 2026-09-10 15:07:04
本页由 Scihuhuan.com 学术互换提供文献检索、引用与获取指引；论文版权和出版身份归原出版方。
引用格式
同来源相关文献
Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis2024 · Vascular PharmacologyMesenchymal progenitor cells in perivascular niches: forerunners of mesenchymal stem cells and players in tissue scarring and regeneration2025 · Vascular PharmacologyElucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging2025 · Vascular PharmacologyRNA-seq and ChIP-seq reveal microplastics induce endothelial-mesenchymal transition via HK2-mediated histone lactylation in pulmonary hypertension2026 · Vascular PharmacologyExploring the significance of epicardial adipose tissue in aortic valve stenosis and left ventricular remodeling: Unveiling novel therapeutic and prognostic markers of disease2023 · Vascular PharmacologyEarly haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction2005 · Vascular Pharmacology